Background illustration for clinical trials search

Paid Clinical Trials Fresno

Discover 161 paid clinical trials in Fresno, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Fresno CA, Modesto CA, Bakersfield CA, Salinas CA,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for
Metastatic Salivary Gland Carcinoma,
Location: Fresno CA, Modesto CA, San Jose CA, Santa Clara CA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase 2, Recruiting

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

for
Prostate Cancer
Location: Fresno CA, Modesto CA, San Jose CA, Stockton CA,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06235697

Phase 3, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for
Ovarian Carcinoma
Location: Fresno CA, Modesto CA, San Jose CA, Stockton CA,
Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Fresno CA, Modesto CA, San Jose CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Fresno CA, Modesto CA, San Jose CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Fresno CA, San Jose CA, Santa Clara CA, Palo Alto CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Fresno CA, Modesto CA, San Jose CA, Stockton CA,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for
Metastatic Nasopharyngeal Carcinoma,
Location: Fresno CA, Modesto CA, San Jose CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Fresno CA, Modesto CA, San Jose CA, Santa Clara CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase 2, Phase 3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Fresno CA, Modesto CA, San Jose CA, Stockton CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Fresno CA, Madera CA, Modesto CA, San Jose CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase 3, Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Fresno CA, Clovis CA, Modesto CA, San Luis Obispo CA,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Fresno CA, Modesto CA, San Jose CA, Arroyo Grande CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase 2, Recruiting

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

for
Pulmonary Hypertension, Interstitial Lung Disease
Location: Fresno CA, Phoenix AZ, Bend OR, Denver CO,
Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06129240

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Fresno CA, Salinas CA, Oxnard CA, Granada Hills CA,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase 2, Phase 3, Recruiting

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

for
Hematuria - Cause Not Known
Location: Fresno CA, Los Angeles CA, Dallas TX, Madison WI,
Sponsor: Pacific Edge Limited

Sex: All

Age: 18 - 70+

Code: NCT06394869

Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Fresno CA, Bakersfield CA, Santa Monica CA,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Fresno CA, Duarte CA, San Diego CA, Springfield OR,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for
Prostate Adenocarcinoma
Location: Fresno CA, San Francisco CA, Portland OR, Milwaukee WI,
Sponsor: Alessa Therapeutics Inc.

Sex: Male

Age: 21+

Code: NCT06257693

Phase 1, Recruiting